Article (Scientific journals)
Pharma clinics le medicament du mois. L'esomeprazole
Louis, Edouard
2002In Revue Médicale de Liège, 57 (9), p. 610-2
Peer reviewed
 

Files


Full Text
Pharma Clinics - Esoméprazole - RMLg 2002.pdf
Publisher postprint (439.79 kB)
Download

All documents in ORBi are protected by a user license.

Send to



Details



Abstract :
[en] Esomeprazole is the last PPI registered on the Belgian market. It is the stable s-isomer of omeprazole. It has a better pharmacokinetic profile than omeprazole (racemate), allowing also better clinical performances. Esomeprazole is the first PPI shown superior to omeprazole in acute and chronic treatment of gastro-esophageal reflux disease. Controlled trials with this drug have also allowed to define new cost-effective strategies, such as on demand treatment for endoscopy-negative gastro-esophageal reflux and one week treatment of Helicobacter pylori positive duodenal ulcer.
Disciplines :
Gastroenterology & hepatology
Author, co-author :
Louis, Edouard  ;  Université de Liège - ULiège > Département des sciences cliniques > Hépato-gastroentérologie
Language :
French
Title :
Pharma clinics le medicament du mois. L'esomeprazole
Alternative titles :
[en] Pharma Clinics Medication of the Month. Esomeprazole
Publication date :
September 2002
Journal title :
Revue Médicale de Liège
ISSN :
0370-629X
eISSN :
2566-1566
Publisher :
Université de Liège. Revue Médicale de Liège, Liège, Belgium
Volume :
57
Issue :
9
Pages :
610-2
Peer reviewed :
Peer reviewed
Available on ORBi :
since 05 October 2009

Statistics


Number of views
147 (2 by ULiège)
Number of downloads
154 (2 by ULiège)

Scopus citations®
 
0
Scopus citations®
without self-citations
0

Bibliography


Similar publications



Contact ORBi